ASHLEY BREWSTER: Open Payments
NPI 1962960708 · NORTH KANSAS CITY, MO. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$2,493 in 105 payments from 38 companies in 2025. Trend: 2023 $972 · 2024 $2,601 · 2025 $2,493
Food & beverage: $2,493
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 14 | $619 |
| Axsome Therapeutics, Inc. | 3 | $151 |
| PFIZER INC. | 13 | $148 |
| Lundbeck LLC | 7 | $139 |
| Vanda Pharmaceuticals Inc. | 4 | $109 |
| UCB, Inc. | 4 | $75 |
| ARGENX US, INC. | 3 | $68 |
| Genentech USA, Inc. | 3 | $68 |
| ANI Pharmaceuticals, Inc. | 3 | $66 |
| Lilly USA, LLC | 3 | $61 |
Products named: QULIPTA, Symbravo, NURTEC ODT, VYEPTI, PONVORY, BOTOX, REXULTI, VYVGART HYTRULO.
Industry payments across MO — which companies pay providers there.
